DAFNA Capital Management’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-438,884	Closed	-$2.65M	–	90
2019 Q4	$2.65M	Hold	438,884	–	–	0.91%	25
2019 Q3	$1.58M	Sell	438,884 -166,000	-27%	-$598K	0.59%	42
2019 Q2	$1.62M	Sell	604,884 -16,298	-3%	-$43.7K	0.61%	46
2019 Q1	$1.84M	Sell	621,182 -9,000	-1%	-$26.6K	0.79%	38
2018 Q4	$1M	Sell	630,182 -217,454	-26%	-$346K	0.5%	48
2018 Q3	$3.12M	Sell	847,636 -100,000	-11%	-$368K	1.28%	26
2018 Q2	$2.68M	Buy	947,636 +79,364	+9%	+$225K	1.26%	24
2018 Q1	$3.22M	Sell	868,272 -80,000	-8%	-$297K	1.57%	23
2017 Q4	$2.73M	Buy	948,272 +230,000	+32%	+$662K	1.47%	24
2017 Q3	$3.23M	Buy	718,272 +451,772	+170%	+$2.03M	2%	13
2017 Q2	$1.22M	Buy	266,500 +70,000	+36%	+$321K	0.87%	37
2017 Q1	$827K	Hold	196,500	–	–	0.7%	41
2016 Q4	$812K	Buy	196,500 +10,000	+5%	+$41.3K	0.71%	43
2016 Q3	$1.51M	Sell	186,500 -50,000	-21%	-$405K	1.05%	35
2016 Q2	$1.85M	Hold	236,500	–	–	1.46%	20
2016 Q1	$1.83M	Hold	236,500	–	–	1.58%	20
2015 Q4	$2.55M	Sell	236,500 -243,800	-51%	-$2.63M	2.27%	14
2015 Q3	$3.32M	Hold	480,300	–	–	3.29%	5
2015 Q2	$4.26M	Buy	480,300 +238,700	+99%	+$2.11M	3.6%	4
2015 Q1	$2.38M	Buy	241,600 +44,100	+22%	+$435K	1.83%	14
2014 Q4	$2.42M	Buy	197,500 +171,500	+660%	+$2.1M	1.91%	16
2014 Q3	$259K	Buy	+26,000	New	+$259K	0.26%	48
2013 Q4	–	Sell	-121,800	Closed	-$368K	–	53
2013 Q3	$368K	Hold	121,800	–	–	0.4%	43
2013 Q2	$996K	Buy	+121,800	New	+$996K	1.46%	16